Antituberculous Activity and Toxicity of Lupulon for the Mouse.
Y.-C. Chin, Harold Anderson, Gemma Alderton, Justin Lewis
Abstract
Y.-C. Chin, Harold Anderson, Gemma Alderton, Justin Lewis
Abstract
Lupulon, a fat-soluble antibiotic derived from hops, has relatively low in vitro activity (1:40,000) as compared with other antituberculous agents. Despite this observation, lupulon (given orally or intramuscularly) was active against experimental mouse infections of M. tuberculosis. Following intramuscular administration, significantly lower numbers of acid-fast organisms occurred in lesions of treated animals. The approximate numbers relative to the control were: In the liver, 34 to 1; heart, 8 to 1; spleen, 4 to 1; and lungs, 4 to 1; but not in the kidneys. In orally treated animals the ratios were: Liver, 10 to 1; heart, 3 to 1; spleen, 10 to 1; lungs, 5 to 1, and kidneys, 2 to 1. The over-all difference was a reduction of approximately 4 to 1 by either route of administration.
OpenAlex reports 37 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Lupulon, a fat-soluble antibiotic derived from hops, has relatively low in vitro activity (1:40,000) as compared with other antituberculous agents. Despite this observation, lupulon (given orally or intramuscularly) was active against experimental mouse infections of M. tuberculosis. Following intramuscular administration, significantly lower numbers of acid-fast organisms occurred in lesions of treated animals. The approximate numbers relative to the control were: In the liver, 34 to 1; heart, 8 to 1; spleen, 4 to 1; and lungs, 4 to 1; but not in the kidneys. In orally treated animals the ratios were: Liver, 10 to 1; heart, 3 to 1; spleen, 10 to 1; lungs, 5 to 1, and kidneys, 2 to 1. The over-all difference was a reduction of approximately 4 to 1 by either route of administration.
Key concepts: Spleen, Toxicity, Pharmacology, Antibiotics, In vitro, Oral administration, Medicine, Kidney